Table 3.
Demographic, Pulmonary Function Test, Laboratory Variables and Tuberculin Skin Test in TBB Positive and Negative Groups
| Variables | Positive Biopsy (n: 25) | Negative Biopsy (n: 38) | P-value |
|---|---|---|---|
| Demographic | |||
| Age (years) | 44,0 ± 11,7 | 46,6 ± 12,2 | 0.39 |
| Female, n (%) | 20 -40.8 | 29 -59.2 | 0.731 |
| Smoker, n (%) | 9 -60 | 6 -40 | 0.059 |
| Pulmonary Function Test | |||
| FEV1 (ml) | 2310.4 ± 787.7 | 2448.2 ± 777.0 | 0.641 |
| FEV1 (% predicted) | 83.8 ± 21.9 | 89.1 ± 22.2 | 0.371 |
| FVC (ml) | 2991.7 ± 944.0 | 3006.3 ± 1033.3 | 0.931 |
| FVC (% predicted) | 88.3 ± 18.8 | 93.8 ± 20.1 | 0.29 |
| FEV1/FVC | 77 ± 10.9 | 79.2 ± 9.9 | 0.219 |
| DLCOADJ (% predicted) | 74.9 ± 26.9 | 108.8 ± 168.4 | 0.422 |
| DLCOVA (% predicted) | 94 ± 17.5 | 88.9 ± 22.0 | 0,584 |
| Laboratory Data | |||
| ACE U/L | 78.2 ± 59.9 | 76.7 ± 68.1 | 0.479 |
| Blood Ca level (mg/dl) | 9.3 ± 0.4 | 9.3 ± 0.6 | 0.211 |
| Urine Ca Level (mg/dl) | 205.3 ± 133.0 | 184.4 ± 200.8 | 0.721 |
| ESR (mm/h) | 35.1 ± 20.5 | 35.8 ± 27.8 | 0.628 |
| Clinical Data | |||
| Tuberculin Skin Test (mm) | 0.1 ± 0.3 | 2.2 ± 6.9 | 0.348 |
Data were presented as mean± SD. SD, Standard deviation